Manufacturing medicines in space: how astronauts will make their own drugs
NASA’s TRISH has funded innovative projects seeking to better protect astronauts' health during deep space missions. Two of the six...
Focus:
-
![Janssen’s Stelara not recommended by NICE as second line UC treatment]()
Janssen’s Stelara not recommended by NICE as second line UC treatment
-
![Coronavirus and MERS-CoV: Major drugs in the pipeline]()
Coronavirus and MERS-CoV: Major drugs in the pipeline
-
![Coronavirus outbreak: the story so far]()
Coronavirus outbreak: the story so far
-
![Stop ignoring the two billion: pharma’s role in expanding access to medicine]()
Stop ignoring the two billion: pharma’s role in expanding access to medicine
-
![BioNTech acquires T cell therapy-focused Neon for $67m]()
BioNTech acquires T cell therapy-focused Neon for $67m
-
![NICE cancer guidance: good news for Ibrance and Lynparza]()
NICE cancer guidance: good news for Ibrance and Lynparza
Expert commentary & analysis from GlobalData
What does Big Pharma’s capital expenditure mean for CMOs?
NICE fails to recommend Stelara for ulcerative colitis
Cervical Health Awareness Month: highlighting cervical cancer and HPV
Q3 Market caps: growth for large cap companies while mega caps decline
Most Read
Company releases
Granulation Variety
Granulation continues to grow in importance in the pharmaceutical industry due to the increasing pressures related to cost in the...
Modality Solutions Announces 2019 Year-End Milestones
FPS to Attend Next DUPHAT Tech in Dubai, 25-27 February
FPS is proud to announce its participation at DUPHAT Tech show in Dubai on 25-27 February.
Gerresheimer, Portal Instruments Develop Novel Primary Packaging
TrialScope Unveils EMD Serono’s Clinical Trials Website
TrialScope has collaborated with EMD Serono to launch an innovative clinical trials website: https://clinicaltrials.emdgroup.com.
Company whitepapers
Pharmaceutical Cold Chain Management
Win Transport ItalyDischarging Drums for Loss-in-Weight Systems
HECHTPrecision and Ease-of-Use for R&D Instruments
MedelpharmCase Study: West Pharmaceutical Services
Modality SolutionsAstraZeneca Takes an Innovative Approach to Trial Results Summaries
TrialScopeKlocke uses NA and ML for Quality Storage
MuntersAbiogen Pharma Brochure
Abiogen PharmaCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
STA Pharmaceutical’s Manufacturing Facility, Changzhou
STA Pharmaceutical (STA), a subsidiary of WuXi AppTec, opened its new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China, in January 2020.
GE Healthcare Viral Vector Manufacturing Facility, Worcester
Rentschler Biopharmaceutical Manufacturing Facility Expansion
Novartis Stein Cell and Gene Therapy Facility
Parsolex’s CGMP Manufacturing Facility Expansion, West Lafayette, Indiana
Clinical Trials
Janssen’s Stelara not recommended by NICE as second line UC treatment
The UK’s pricing regulator the National Institutes of Health and Social Care (NICE) has not recommended Janssen’s Stelara (ustekinumab) for routine NHS use as a...
Promethera closes Series D funding round to support expansion
Data shows non-inferiority of SC administration of Roche’s Perjeta and Herceptin
Janssen’s Darzalex outperforms standard of care in newly diagnosed multiple myeloma
ViiV submits NDA for drug indicated for multi-drug resistant HIV
Design
Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
USPTO reverses decision regarding interfering CRISPR patents
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
ProAmpac updates child-resistant pouch product line
Drug Development
Zydus licenses anaemia drug to China Medical System
Pharmaceutical company Zydus Cadila has signed a licensing agreement with China Medical System (CMS) to develop and commercialise an anaemia drug Desidustat in Greater China.
US scientists discover anti-cancer use for non-oncology drugs
BioNTech acquires T cell therapy-focused Neon for $67m
Dermavant licences Tapinarof commercial rights in Japan
Galapagos expands fibrosis research collaboration with Fibrocor
Market Data
GSK paroxetine generics deals may be anti-competitive in Europe
A legal adviser to the European Court of Justice (ECJ) said that the deals signed by GlaxoSmithKline (GSK) to delay the market availability of generics...
US judge cuts damages in J&J’s Risperdal case from $8bn to $6.8m
US proposes rules for drug importation from Canada
Roche gets UK and US clearances for Spark Therapeutics acquisition
WHO announces pilot for insulin prequalification
Technology
Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
Flagship Pioneering launches Cellarity for cell behaviour drugs
Boehringer partners with Healx for AI-based drug discovery
Novartis partners with Amazon for digital boost to manufacturing
Orexo acquires US rights to commercialise vorvida
Your recommended content
Supporting mental health in a business environment
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Go Top